Norway vs Algeria vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 94% |
| 2023 | 96% | 99% |
| 2022 | 96% | 79% |
| 2021 | 97% | 79% |
| 2020 | 97% | 80% |
| 2019 | 97% | 80% |
| 2018 | 96% | 80% |
| 2017 | 96% | 88% |
| 2016 | 96% | 94% |
| 2015 | 95% | 95% |
| 2014 | 94% | 95% |
| 2013 | 93% | 95% |
| 2012 | 94% | 95% |
| 2011 | 93% | 95% |
| 2010 | 93% | 95% |
| 2009 | 93% | 92% |
| 2008 | 93% | 88% |
| 2007 | 92% | 92% |
| 2006 | 92% | 91% |
| 2005 | 90% | 83% |
| 2004 | 89% | 81% |
| 2003 | 86% | 84% |
| 2002 | 87% | 81% |
| 2001 | 90% | 83% |
| 2000 | 88% | 80% |
| 1999 | 90% | 83% |
| 1998 | 91% | 84% |
| 1997 | 93% | 92% |
| 1996 | 92% | 90% |
| 1995 | 92% | 89% |
| 1994 | 94% | 88% |
| 1993 | 93% | 87% |
| 1992 | 96% | 86% |
| 1991 | 94% | 85% |
| 1990 | 87% | 83% |
| 1989 | 84% | 82% |
| 1988 | 87% | 81% |
| 1987 | 87% | 73% |
| 1986 | 87% | 67% |
| 1985 | 90% | 68% |
| 1984 | 80% | - |
| 1983 | 80% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 92% |
| 2023 | 96% | 92% |
| 2022 | 97% | 77% |
| 2021 | 97% | 81% |
| 2020 | 97% | 84% |
| 2019 | 97% | 88% |
| 2018 | 96% | 91% |
| 2017 | 96% | 91% |
| 2016 | 96% | 91% |
| 2015 | 95% | 95% |
| 2014 | 93% | 95% |
| 2013 | 94% | 95% |
| 2012 | 95% | 95% |
| 2011 | 94% | 95% |
| 2010 | 93% | 95% |
| 2009 | 94% | 95% |
| 2008 | 94% | 93% |
| 2007 | 93% | 95% |
| 2006 | 94% | 95% |
| 2005 | 91% | 88% |
| 2004 | 92% | 86% |
| 2003 | 92% | 87% |
| 2002 | 93% | 86% |
| 2001 | 91% | 89% |
| 2000 | 90% | 86% |
| 1999 | 92% | 83% |
| 1998 | 93% | 85% |
| 1997 | 95% | 89% |
| 1996 | 97% | 88% |
| 1995 | 97% | 88% |
| 1994 | 93% | 87% |
| 1993 | 94% | 88% |
| 1992 | 98% | 88% |
| 1991 | 96% | 89% |
| 1990 | 86% | 89% |
| 1989 | 83% | 87% |
| 1988 | 83% | 85% |
| 1987 | 80% | 79% |
| 1986 | 83% | 73% |
| 1985 | 85% | 69% |
| 1984 | 90% | - |
| 1983 | 90% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 92% |
| 2023 | 96% | 94% |
| 2022 | 96% | 77% |
| 2021 | 96% | 81% |
| 2020 | 97% | 84% |
| 2019 | 96% | 88% |
| 2018 | - | 91% |
| 2017 | - | 91% |
| 2016 | - | 91% |
| 2015 | - | 95% |
| 2014 | - | 95% |
| 2013 | - | 95% |
| 2012 | - | 95% |
| 2011 | - | 95% |
| 2010 | - | 95% |
| 2009 | - | 94% |
| 2008 | - | 91% |
| 2007 | - | 90% |
| 2006 | - | 80% |
| 2005 | - | 83% |
| 2004 | - | 81% |
| 2003 | - | - |
| 2002 | - | - |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
| 1986 | - | - |
| 1985 | - | - |
| 1984 | - | - |
| 1983 | - | - |
The first measles dose reaches 96% of children aged 12–23 months in Norway and 94% in Algeria: 2 percentage points more in Norway. The third DTP dose reaches 97% in Norway and 92% in Algeria, 5 points more in Norway. The third hepatitis B dose reaches 96% in Norway and 92% in Algeria, 4 points more in Norway. In 1985, the first measles dose reached 90% in Norway and 68% in Algeria, 22 percentage points more in Norway.
Norway vs Algeria: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 96% (2024) | 94% (2024) |
| DTP3 | 97% (2024) | 92% (2024) |
| HepB3 | 96% (2024) | 92% (2024) |
Norway and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Algeria and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Norway and its three neighbors, the latest coverage of the first measles dose is highest in Russia, at 97%, and lowest in Sweden, at 93%; of Algeria and its six neighbors, the latest coverage of the first measles dose is highest in Morocco, at 98%, and lowest in Mali, at 72%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1983–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.